Skip to main content
Mariusz Wasik, MD, Pathology, Philadelphia, PA, Fox Chase Cancer Center

MariuszAndrzeWasikMD

Pathology Philadelphia, PA

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology & Laboratory Medicine, Perelman School of Medicine

Dr. Wasik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wasik's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematopathology, 1992 - 1993
  • Boston University Medical Center
    Boston University Medical CenterResidency, Pathology-Anatomic and Clinical, 1988 - 1991
  • Wroclaw Medical University
    Wroclaw Medical UniversityClass of 1979

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1993 - 2024
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Hematology

Publications & Presentations

PubMed

Journal Articles

  • LRPAP1 Is a Frequent Proliferation-Inducing Antigen of BCRs of Mantle Cell Lymphomas and Can Be Used for Specific Therapeutic Targeting  
    Stephen J Schuster, Mariusz Wasik, Nature

Press Mentions

  • Mariusz Wasik Joins Fox Chase Cancer Center as Chair of Pathology
    Mariusz Wasik Joins Fox Chase Cancer Center as Chair of PathologyMay 23rd, 2018

Grant Support

  • Novel Role Of STAT3 In Npm/Alk-Induced OncogenesisNational Cancer Institute2009–2012
  • JAK/STAT Signaling In Human T-Cell LymphomasNational Cancer Institute2006–2010
  • (M) TOR Signaling In Ebv-Associated LymphomasNational Institute Of Dental &Craniofacial Research2005–2007
  • Dysregulation Of STAT3 In Alk-Induced OncogenesisNational Cancer Institute2002–2006
  • Aberrant JAK/STAT Signaling In Cutaneous T Cell LymphomaNational Cancer Institute2001–2005
  • IL 2R Signaling Pathways In T Cell LymphomaNational Cancer Institute1999

Hospital Affiliations